San Diego, California--(Newsfile Corp. - September 14, 2022) - Hempacco Co., Inc. (NASDAQ: HPCO) ("Hempacco" or the "Company"), a vertically integrated hemp manufacturing company, is showcasing its hemp cigarettes, CBD cigarettes, and rolling paper products at InterTabac, the world's leading trade fair for tobacco products and smokers' supplies, taking place September 15-17 at Messe Westfalenhallen Dortmund in Dortmund, Germany.
Hempacco will hold private meetings with interested distributors, retailers, wholesalers, and buyers during the event. To schedule a meeting or to gain access to the event, please contact Hempacco CEO Sandro Piancone at 619-254-2720 or sandro@hempaccoinc.com.
"We look forward to meeting with potential distributors and retailers at InterTabac, Europe's largest tobacco trade show," commented Piancone. "The cigarette market in Europe is expected to reach an estimated $360 billion by 2026, up from just over $200 billion in 2018, according to Forbes. We believe our growing portfolio of hemp products provide a tremendous alternative to tobacco and look forward to gaining further traction in Europe as we continue to expand our mission of Disrupting Tobacco™ around the world."
Hempacco's team will be Booth #6.A30 with samples from its growing line of hemp-based products and exclusive InterTabac show deals.
About Hempacco
Hempacco Co., Inc.'s goal is Disrupting Tobacco's™ nearly $1 trillion industry with herb and hemp-based alternatives to nicotine cigarettes by manufacturing and marketing herb, spice, and cannabinoid smokables and rolling paper. Hempacco owns The Real Stuff™ functional hemp cigarette and rolling paper brand.
Hempacco's operational segments include:
Manufacturing of smokables and hemp rolling paper
Smokable technology development
The Real Stuff™ brand of functional smokables and rolling paper
Learn more at www.hempaccoinc.com
Order products at www.realstuffsmokables.com
Safe Harbor Statement
This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: (i) potential failure to meet projected development and related targets; (ii) changes in applicable laws or regulations that may impact our products and business; (iii) the effect of the COVID-19 pandemic on the Company and its current or intended markets; and (iv) other risks and uncertainties described herein, as well as those risks and uncertainties discussed from time to time in other reports and other public filings with the Securities and Exchange Commission (the "SEC") by the Company. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.
For investor inquiries, please contact:
Dave Gentry
RedChip Companies Inc.
1-800-RED-CHIP (733-2447)
Or 407-491-4498
HPCO@redchip.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/137181
